Back to Search
DANUTA DEEB, MD
MD
Pediatrics Physician
NPI: 1275580557Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
ME45729(FL)
Research & Publications (15)
Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.
PMID 19555200·Immunopharmacol Immunotoxicol·2009
7-preclinical
Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
PMID 19189297·Prostate·2009
7-preclinical
Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
PMID 19192720·Oncol Res·2008
7-preclinical
Imaging Mouse Prostate Gland by 3 Tesla Clinical MRI System.
PMID 19011697·Open Magn Reson Rev·2008
8-other
Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.
PMID 18608528·Immunopharmacol Immunotoxicol·2008
4-observational
CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
PMID 18472640·J Exp Ther Oncol·2008
7-preclinical
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
PMID 17289836·J Pharmacol Exp Ther·2007
8-other
Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
PMID 17361329·J Neurooncol·2007
8-other
Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse.
PMID 16528969·J Exp Ther Oncol·2006
7-preclinical
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
PMID 16471035·J Exp Ther Oncol·2005
8-other
Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.
PMID 16416600·J Exp Ther Oncol·2005
8-other
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
PMID 15252141·Mol Cancer Ther·2004
8-other
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
PMID 15183117·Biochem Pharmacol·2004
7-preclinical
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects.
PMID 14637200·Biochem Pharmacol·2003
7-preclinical
Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells.
PMID 12533677·Mol Cancer Ther·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2902 N ORANGE AVE, SUITE D
ORLANDO, FL 32804 - Phone
- (407) 898-4116
Quick Facts
- NPI
- 1275580557
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile